A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

A Yale University study uncovers how gut bacteria imbalances may trigger multiple sclerosis (MS), offering new insights into ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...

A new study has found that the gut microbiome plays a crucial role in the development of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system. The findings may ...

Multiple Sclerosis Market Growth is Driven by Advanced Treatment Solutions and Rising Patient PopulationsPune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size & Growth Analysis: ...

Brii Biosciences Inc. has identified substituted 2-(3,5-dichloro-4-(4-hydroxy-benzyl)phenoxy)acetamide derivatives that are prodrugs of thyroid hormone receptor β (TH-β) agonists and reported to be ...

A new study found no significant benefit in adding low-dose oral glucocorticoids to immunosuppressive therapy for improving ...

Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...